Evaluation of a “one-stop shop” for integrated harm reduction and primary care for people who inject drugs
In this first comprehensive analysis of a large SSP since its inception and through the COVID-19 pandemic, we described important client characteristics and utilization of an array of syringe services from an integrated SSP. Findings suggest the SSP attracts a high volume of clients, provides on-demand services, and reaches a wide range of clients. Future research is needed to evaluate the impact of the program's home-delivery service and increased outreach efforts. Despite limitations, the program's success demonstrates the SSP can serve as a model for other harm reduction programs nationally.
Authors
- Katherine M. Rich (ORCID: https://orcid.org/0000-0002-2767-2355)
- Luis Álvarez (ORCID: https://orcid.org/0000-0003-1316-1906)
- Frederick L. Altice (ORCID: https://orcid.org/0000-0002-7860-693X)
- Jaimie P. Meyer (ORCID: https://orcid.org/0000-0001-5735-385X)
- Natalie Kil
- Terry Jones (ORCID: https://orcid.org/0009-0007-8442-2233)
- N A Ibrahim (ORCID: https://orcid.org/0009-0009-4409-767X)
- Carolina Price
Institutions
- SIL International (US)
- Harvard University (US)
- Yale University (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1371/journal.pone.0337528
- Primary Topic
- HIV, Drug Use, Sexual Risk
- Type
- article
- Field-Weighted Citation Impact
- 0.00